Evofem Biosciences, Inc. (EVFM)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 1.1000 |
| Open | 0.4950 |
| Bid | 0.4040 x 1200 |
| Ask | 0.4097 x 1300 |
| Day's Range | 0.4000 - 0.5001 |
| 52 Week Range | 0.4000 - 21.3000 |
| Volume | |
| Avg. Volume | 631,458 |
| Market Cap | 5.15M |
| Beta (5Y Monthly) | -0.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -19.0060 |
| Earnings Date | Aug 09, 2022 - Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 26.75 |
- Simply Wall St.
Shareholders in Evofem Biosciences (NASDAQ:EVFM) are in the red if they invested a year ago
Evofem Biosciences, Inc. ( NASDAQ:EVFM ) shareholders should be happy to see the share price up 15% in the last month...
- CNW Group
Evofem Biosciences and Orion Biotechnology Launch Collaboration to Develop MPT Product Candidate to Include HIV Prevention
Evofem Biosciences, Inc. (NASDAQ: EVFM) and Orion Biotechnology Canada Ltd. today announced that they have entered into a collaboration agreement to evaluate the compatibility and stability of Orion's novel CCR5 antagonist, OB-002, in Evofem's Phexxi® (lactic acid, citric acid and potassium bitartrate) vaginal gel with the goal of developing a Multipurpose Prevention Technology (MPT) product candidate for indications including the prevention of HIV in women.
- Simply Wall St.
Evofem Biosciences (NASDAQ:EVFM) shareholders have endured a 78% loss from investing in the stock three years ago
Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So...
© 2022 Yahoo. All rights reserved.
